Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy in Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02022852
What this trial is testing

Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer

Who this might be right for
Rectal Cancer
Harbin Medical University 80
Testing effectiveness (Phase 2)UnknownNCT03022734
What this trial is testing

Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis

Who this might be right for
Rectal Cancer, Metastatic
Yonsei University 40
Not applicableUnknownNCT03824899
What this trial is testing

UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fudan University 100
Not applicableUnknownNCT02554448
What this trial is testing

Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy

Who this might be right for
Rectal NeoplasmsCirculating Tumor Cells
Sixth Affiliated Hospital, Sun Yat-sen University 80
Early research (Phase 1)Study completedNCT01740648
What this trial is testing

Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Who this might be right for
Recurrent Rectal CancerStage IIA Rectal CancerStage IIB Rectal Cancer+4 more
Ohio State University Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT06176885
What this trial is testing

Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
yue junhan 36
Testing effectiveness (Phase 2)Study completedNCT00330915
What this trial is testing

Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

Who this might be right for
Rectal Neoplasms
Eli Lilly and Company 37
Not applicableWithdrawnNCT04670588
What this trial is testing

Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Medical College of Wisconsin
Testing effectiveness (Phase 2)Active Not RecruitingNCT05009069
What this trial is testing

Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Cancer
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)UnknownNCT04621370
What this trial is testing

A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Neoplasms
Liz-Anne Lewsley 48
Testing effectiveness (Phase 2)Study completedNCT02921256
What this trial is testing

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v7Stage III Rectal Cancer AJCC v7
National Cancer Institute (NCI) 363
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07403877
What this trial is testing

Neoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer (MSI-H)
Fudan University 114
Not applicableStudy completedNCT04271657
What this trial is testing

RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)Looking for participantsNCT06928584
What this trial is testing

Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer

Who this might be right for
Locally Recurrent Rectal Cancer
Fudan University 221
Testing effectiveness (Phase 2)Looking for participantsNCT06542588
What this trial is testing

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC

Who this might be right for
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 29
Not applicableUnknownNCT04456283
What this trial is testing

Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy

Who this might be right for
Cancer of RectumLymph Node Disease
University of Sao Paulo 250
Not applicableUnknownNCT03002727
What this trial is testing

Role of CD133 & Microsatellite Status in Evaluation of Rectosigmoid Cancer Young Adults Received Neoadjuvant Treatment

Who this might be right for
Colorectal Cancer GeneticsYoung Adult
Assiut University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07239466
What this trial is testing

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerRadiotherapyImmunotherapy+1 more
Tao Zhang 25
Testing effectiveness (Phase 2)Study completedNCT00814619
What this trial is testing

Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 68
Testing effectiveness (Phase 2)UnknownNCT04423965
What this trial is testing

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

Who this might be right for
Locally Advanced Rectal Cancer
First Affiliated Hospital of Zhejiang University 220
Next Page